NCT06404645 A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma
| NCT ID | NCT06404645 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RenJi Hospital |
| Condition | Intracranial Hemorrhages |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2024-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2024-05-01 with a primary completion date of 2024-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial is a clinical prospective observational study. Cases meeting the entry criteria undergo near-infrared spectroscopy(NIRS）detection. Data collection mainly includes hematoma thickness on cranial CT, and bilateral NIRS data.This trial tries to explore the reliability and accuracy of NIRS detection of subcranial hematoma.
Eligibility Criteria
Inclusion Criteria: 1. Age above 18 years old 2. Unilateral subcranial hemorrhage confirmed by cranial CT Exclusion Criteria: 1. Bilateral subcranial hemorrhage 2. Intracranial pneumoperitoneum in the location of the hemorrhage on cranial CT 3. Obvious skull fracture in the location of hemorrhage on cranial CT
Contact & Investigator
Junfeng Feng
STUDY CHAIR
RenJi Hospital
Frequently Asked Questions
Who can join the NCT06404645 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intracranial Hemorrhages. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06404645 currently recruiting?
Yes, NCT06404645 is actively recruiting participants. Contact the research team at gongru1987@126.com for enrollment information.
Where is the NCT06404645 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06404645 clinical trial?
NCT06404645 is sponsored by RenJi Hospital. The principal investigator is Junfeng Feng at RenJi Hospital. The trial plans to enroll 20 participants.